TaiGen filed US IND for its influenza antiviral TG-1000

"We are excited about the IND filing in the US for the internally developed TG-1000 which has the potential to be a single dose treatment for influenza."

100420 TaiGen filed US IND for its influ
.
Download • 42KB

Recent Posts

See All

Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887

Website: www.medicalandpharmainsider.com

Email mail@medicalandpharmainsider.com

MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2020 by Medical and Pharma Insider and FC Global Strategies LLC